• Thursday, Jul 07, 2022
  • Last Update : 04:24 pm

Pfizer to start pilot delivery program for its Covid-19 vaccine in four US states

  • Published at 12:46 pm November 17th, 2020
Pfizer Covid-19 Vaccine
File photo of Vials with a sticker reading, ‘Covid-19' and a medical syringe are seen in front of a displayed Pfizer logo in this illustration taken on October 31, 2020 Reuters

Pfizer and its partner BioNTech have a $1.95 billion deal to supply 100 million doses of the vaccine to the US government

Pfizer Inc has launched a pilot delivery program for its experimental Covid-19 vaccine in four US states, as the US drugmaker seeks to address distribution challenges facing its ultra-cold storage requirements.

Pfizer’s vaccine, which was shown to be more than 90% effective in preventing Covid-19 based on initial data, must be shipped and stored at -70˚C (minus 94°F), significantly below the standard for vaccines of 2-8˚C (36-46°F).

“We are hopeful that results from this vaccine delivery pilot will serve as the model for other US states and international governments, as they prepare to implement effective Covid-19 vaccine programs,” Pfizer said in a statement on Monday.

It picked Rhode Island, Texas, New Mexico, and Tennessee for the program after taking into account their differences in overall size, diversity of populations, immunization infrastructure, and need to reach individuals in varied urban and rural settings.


Also read: Pfizer vaccine could be cold comfort for Bangladesh, Asian nations


The four states will not receive vaccine doses earlier than other states by virtue of the pilot, nor will they receive any differential consideration, Pfizer said.

The company expects to have enough safety data on the vaccine from the ongoing large scale late-stage trials by the third week of November before proceeding to apply for emergency use authorization (EUA).

Pfizer and its partner BioNTech have a $1.95 billion deal to supply 100 million doses of the vaccine to the US government, which has an option to acquire up to an additional 500 million doses.

Earlier on Monday, rival Moderna Inc said its experimental vaccine was 94.5% effective in preventing Covid-19 based on interim data from a late-stage trial, boosting hopes that vaccines against the disease may be ready for use soon.

Both the Pfizer and Moderna vaccines use a new technology called synthetic messenger RNA to activate the immune system against the virus.

50
Facebook 50
blogger sharing button blogger
buffer sharing button buffer
diaspora sharing button diaspora
digg sharing button digg
douban sharing button douban
email sharing button email
evernote sharing button evernote
flipboard sharing button flipboard
pocket sharing button getpocket
github sharing button github
gmail sharing button gmail
googlebookmarks sharing button googlebookmarks
hackernews sharing button hackernews
instapaper sharing button instapaper
line sharing button line
linkedin sharing button linkedin
livejournal sharing button livejournal
mailru sharing button mailru
medium sharing button medium
meneame sharing button meneame
messenger sharing button messenger
odnoklassniki sharing button odnoklassniki
pinterest sharing button pinterest
print sharing button print
qzone sharing button qzone
reddit sharing button reddit
refind sharing button refind
renren sharing button renren
skype sharing button skype
snapchat sharing button snapchat
surfingbird sharing button surfingbird
telegram sharing button telegram
tumblr sharing button tumblr
twitter sharing button twitter
vk sharing button vk
wechat sharing button wechat
weibo sharing button weibo
whatsapp sharing button whatsapp
wordpress sharing button wordpress
xing sharing button xing
yahoomail sharing button yahoomail